Rodeo Therapeutics is a preclinical-stage biopharmaceutical company. It is focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.

Type
Private
HQ
Seattle, US
Rodeo Therapeutics is headquartered in Seattle, US
Report incorrect company information

Key People/Management at Rodeo Therapeutics

Sanford Markowitz

Sanford Markowitz

Founder
Joseph Ready

Joseph Ready

Founder
Stanton Gerson

Stanton Gerson

Founder
Show more

Rodeo Therapeutics Office Locations

Rodeo Therapeutics has an office in Seattle
Seattle, US (HQ)
200 1616 Eastlake Ave E
Show all (1)
Report incorrect company information

Rodeo Therapeutics Financials and Metrics

Summary Metrics

Rodeo Therapeutics total Funding

$5.9 m

Rodeo Therapeutics latest funding size

$5.90 m

Time since last funding

a year ago

Rodeo Therapeutics investors

Rodeo Therapeutics's latest funding round in July 2017 was reported to be $5.9 m. In total, Rodeo Therapeutics has raised $5.9 m
Show all financial metrics
Report incorrect company information

Rodeo Therapeutics Company Life and Culture

Report incorrect company information